New Drugs

Brand/Generic Company Description
Abecma
idecabtagene vicleucel
Celgene

Intravenous T-cell immunotherapy for multiple myeloma.

Abrilada
adalimumab
Pfizer

A biosimilar to Humira.

Adtralza
tralokinumab
Leo

A monoclonal antibody IL-13 inhibitor for moderate/severe atopic dermatitis in adults.

Bambevi
bevacizumab
Apotex

A biosimilar to Avastin.

Braftovi
encorafenib
Pfizer

A kinase inhibitor for unresectable or metastatic melanoma (used with binimetinib).

Brukinsa
zanubrutinib
BeiGene

Oral Bruton tyrosine kinase inhibitor for Waldenström’s macroglobulinemia.

Comirnaty
COVID-19 vaccine, mRNA
Pfizer

Vaccine to prevent COVID-19.

Dojolvi
triheptanoin
Ultragenyx

Oral medium-chain triglyceride for long-chain fatty acid oxidation disorders.

Enhertu
trastuzumab deruxtecan
AstraZeneca

A monoclonal antibody for unresectable/metastatic HER2-positive breast cancer.

Evrysdi
risdiplam
Hoffmann-La Roche

An oral agent for spinal muscular atrophy.

Foclivia
pandemic influenza vaccine
Seqirus

An H5N1 flu vaccine for influenza prevention in officially declared pandemic situations.

Gavreto
pralsetinib
Hoffmann-La Roche

An oral kinase inhibitor for advanced/metastatic non-small cell lung cancer.

Kesimpta
ofatumumab
Novartis

A monoclonal antibody for relapsing-remitting multiple sclerosis.

Kirsty
insulin aspart
BGP Pharma

A biosimilar to NovoRapid.

Ledaga
chlormethine
Recordati Rare Diseases Canada

A topical alkylating agent for mycosis fungoides-type cutaneous T-cell lymphoma.

Leqvio
inclisiran
Novartis

A subcutaneous PCSK9 inhibitor for hypercholesterolemia.

Lumakras
sotorasib
Amgen

An oral KRAS inhibitor for locally advanced/metastatic NSCLC.

Lyumjev
insulin lispro
Lilly

Fast-acting insulin for diabetes.

Mektovi
binimetinib
Pfizer

A kinase inhibitor for unresectable or metastatic melanoma (used with encorafenib).

Minjuvi
tafasitamab
Incyte Biosciences Canada

A monoclonal antibody for relapsed/refractory diffuse large B-cell lymphoma.

Nextstellis
estetrol/drospirenone
Searchlight Pharma

A new combined oral contraceptive.

Nypozi
filgrastim
Tanvex Buiphara (U.S.)

A biosimilar to Neupogen.

Osphena
ospemifene
Duchesnay

Oral SERM for moderate/severe menopausal-associated painful intercourse and/or vaginal dryness, symptoms of vaginal atrophy.

Pemazyre
pemigatinib
Incyte (US)/Innomar Strategies

A protein kinase inhibitor for advanced or metastatic cholangiocarcinoma.

Phesgo
pertuzumab/trastuzumab
Hoffmann-La Roche

Monoclonal antibody fixed-dose combo for early and metastatic breast cancer.

Ponvory
ponesimod
Janssen

Oral sphingosine-1-phosphate receptor 1 modulator for relapsing remitting MS.

Retevmo
selpercatinib
Loxo (US)/Lilly

Oral protein kinase inhibitor for advanced/metastatic NSCLC, thyroid cancer.

Riabni
rituximab
Amgen

A new biosimilar to Rituxan.

Rukobia
fostemsavir
ViiV Healthcare

An oral HIV-1 attachment inhibitor for multidrug-resistant HIV-1 infection.

SpikeVax
elasomeran mRNA vaccine
Moderna

Vaccine to prevent COVID-19.

Sunosi
solriamfetol
Jazz Pharma

Oral dopamine/norepinephrine reuptake inhibitor to improve wakefulness in narcolepsy/obstructive sleep apnea.

Supemtek
influenza vaccine
Sanofi Pasteur

A quadrivalent vaccine for prevention of influenza in adults.

Tecartus
brexucabtagene autoleucel
Gilead Sciences

An immunotherapy agent for relapsed or refractory mantle cell lymphoma.

Tepmetko
tepotinib
EMD Serono

An oral protein kinase inhibitor for non-small cell lung cancer.

Triferic Avnu
ferric pyrophosphate citrate
Rockwell Medical (US)/RMC Healthcare (CAN)

Intravenous iron replacement therapy to maintain hemoglobin in hemodialysis-dependent chronic kidney disease.

Trikafta
elexacaftor/tezacaftor/ ivacaftor
Vertex

An oral CFTR corrector and potentiator for cystic fibrosis.

Trodelvy
sacituzumab govitecan
Gilead Sciences

IV antibody-drug conjugate for advanced or metastatic triple-negative breast cancer.

Truseltiq
infigratinib
QED Therapeutics (US)

Oral kinase inhibitor for cholangiocarcinoma.

Vistaseal
fibrin sealant (human)
Grifols (SA)/J&J Medical

A topical hemostatic to improve hemostasis during surgery.

Vyepti
eptinezumab
Lundbeck

An injectable CGRP-binding antibody for migraine prevention in adults.

Wakix
pitolisant
Endo (Ireland)/ Paladin

An oral H-3 receptor antagonist/inverse agonist for excessive daytime sleepiness/cataplexy in narcolepsy.

Zepzelca
lurbinectedin
Jazz Pharm.

IV alkylating agent for metastatic small cell lung cancer.

Brand/Generic Company Description
Arazlo
tazarotene
Bausch Health

New strength (0.045%) topical lotion for acne.

Breztri Aerosphere
budesonide/glycopyrronium/formoterol
AstraZeneca

New combination inhaler for COPD maintenance.

Bryhali
halobetasol
Bausch Health

New high/super-high potency 0.01% topical steroid lotion for dermatoses and plaque psoriasis.

Cequa
cyclosporine
Sun Pharma

New 0.09% ophthalmic solution for moderate/severe dry eye.

Haloette
etonogestrel/ethinyl estradiol
Searchlight Pharma

Slow release contraceptive vaginal ring.

Inprosub
progesterone
IBSA (Switz)

New subcutaneous formulation for in vitro fertilization treatment.

Myinfla
colchicine
Pendopharm

New extended-release tablet formulation for reduction of atherothrombotic events in adults with CAD.

Onureg
azacitidine
Celgene/BMSquibb

New oral formulation for maintenance therapy in adults with acute myeloid leukemia.

Opsynvi
macitentan/tadalafil
Janssen

New combination formulation endothelin receptor antagonist/PDE5 inhibitor for long-term treatment of PAH.

Vablys
dequalinium
Duchesnay

An intravaginal antiseptic/anti-infective agent for bacterial vaginosis.

Vyndamax
tafamidis
Pfizer

New higher-strength (61 mg) capsule formulation for cardiomyopathy.

Vyxeos
cytarabine/ daunorubicin
Jazz Pharma

New combination antineoplastic liposomal formulation for certain types of acute myeloid leukemia.

Brand/Generic Company Description
Ruzurgi
amifampridine
Médunik Canada

No longer marketed in Canada as Notice of Compliance is invalid. Another formulation of amifampridine (Firdapse) will continue to be available.